Ensartinib for advanced or metastatic non-small-cell lung cancer with MET exon 14 skipping mutations (EMBRACE): a multi-center, single-arm, phase 2 trial
恩沙替尼治疗MET 14号外显子跳跃突变的晚期或转移性非小细胞肺癌(EMBRACE):一项多中心、单臂II期试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103099
Xia, Yang; Tian, Panwen; Zhou, Mo; Zhao, Jun; Jin, Yang; Guo, Zhiyuan; Li, Xiuzhen; Lu, Weina; Miao, Da; Lu, Yuefei; Xu, Wanting; Zhang, Yongchang; Le, Xiuning; Li, Wen